Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Arrowhead Pharmaceuticals (A2RR34.SA) Q3 2023 Earnings
A2RR34.SA
7
Aug
Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-4.7
-2.38
-0.06
2.27
Details
Expected EPS
-3.57627
Actual EPS
-4.70304
Surprise EPS
-1.13
Surprise Percent
+31.51%
Description
Arrowhead Pharmaceuticals (A2RR34.SA) has reported earnings of -4.70304 per share for Q3 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login